Francis Collins says pharmaceutical companies should help bridge the gap between basic science and applications with old drug compounds.
Daily News Roundup
Francis Collins says pharmaceutical companies should help bridge the gap between basic science and applications with old drug compounds.
The Obama administration pledges $200 million for better ways of managing and extracting information from large data sets.
The NIH plans an extra layer of review for scientists with at least $1.5 million in existing grants.
Graduate students ask for more federal research support.
Through a confluence of events, academic medical centers could lose 10 percent of their revenue in the coming years.
GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.
A second advisor for the National Children’s Study resigns in response to changes in study design.
The Federal Research Public Access Act faces stiff opposition from the Association American of Publishers.
NSABB and Congress members voice their opinions about the new developments in the H5N1 research debate.
The federal agency unveils a collection of thousands of genetic tests for some 2,500 diseases.